Improved diagnosis of visceral leishmaniasis in humans and cutaneous leishmaniasis in dogs
To date, the diagnosis of the severe infectious disease leishmaniosis is still highly unreliable in endemic areas of Eastern Africa, since the pathogen occurring in these regions differs from pathogens present in other endemic areas of South Africa and Asia. Moreover, leishmaniasis is also spreading in southern Europe because infected dogs represent a major source of risk for the transmission to humans.
A cost-effective and time-efficient diagnostics was developed which provides a more
reliable diagnosis of leishmaniasis in humans and animals as compared to currently
available diagnostics. This diagnostics is particularly suitable for a use as rapid test,
allowing an uncomplicated application outside of clinics and laboratories and
consequently a more efficient and improved diagnosis of leishmaniasis in hospitals
and in the field.
Further information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Dr. Peter Stumpf
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
All latest news from the category: Technology Offerings
Detecting fluorescence signals from nanoscale thin films
– new possibilities in product labeling. Researchers from INNOVENT e.V. and Ferdinand-Braun-Institut gGmbH have developed a measurement technique that allows to detect nanoscale fluorescent thin films for the first time…
Understanding how microbiota thrive in their human hosts
A research team lead by scientists from the Max Planck Institute for Biology, Tübingen, has now made substantial progress in understanding how gut bacteria succeed in their human hosts on…